DM

David A. Moreno

AB Array Biopharma: 35 patents #11 of 335Top 4%
Genentech: 10 patents #288 of 2,392Top 15%
LO Loxo Oncology: 3 patents #11 of 31Top 40%
Pfizer: 3 patents #1,612 of 5,153Top 35%
EL Eli Lilly: 1 patents #1,742 of 2,858Top 65%
Overall (All Time): #81,326 of 4,157,543Top 2%
39
Patents All Time

Issued Patents All Time

Showing 25 most recent of 39 patents

Patent #TitleCo-InventorsDate
12351571 Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases James F. Blake, Li Ren, Shane M. Walls 2025-07-08
12303509 Compounds for the treatment of BRAF-associated diseases and disorders Patrick Michael DOERNER BARBOUR, Tanna Bettendorf, Dean Russell Kahn, Alex Andrew KELLUM, Ellen Laird +1 more 2025-05-20
12180207 Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases James F. Blake, Li Ren, Tony P. Tang, Shane M. Walls 2024-12-31
11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more 2024-06-04
11964988 Fused heterocyclic compounds as RET kinase inhibitors James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Dean Russell Kahn +9 more 2024-04-23
11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more 2023-12-26
11807651 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more 2023-11-07
11802127 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Mark Laurence Boys, Joshua Ryan Dahlke +3 more 2023-10-31
11691973 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Sydney Taylor BLANCHE, Mark Laurence Boys +9 more 2023-07-04
11648243 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more 2023-05-16
11634409 Compounds for the treatment of BRAF-associated diseases and disorders Patrick Barbour, Katie Keaton BROWN, Adam Cook, Erik James Hicken, Dean Russell Kahn +7 more 2023-04-25
11603374 Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +6 more 2023-03-14
11524963 Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +3 more 2022-12-13
11472802 Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors Shane M. Walls, Li Ren, Ginelle A. Ramann, Andrew T. Metcalf, Elizabeth A. McFaddin +6 more 2022-10-18
11414404 Compounds for the treatment of BRAF-associated diseases and disorders Patrick Barbour, Katie Keaton BROWN, Adam Cook, Erik James Hicken, Dean Russell Kahn +7 more 2022-08-16
11168090 Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more 2021-11-09
11098064 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more 2021-08-24
10953005 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more 2021-03-23
10881652 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more 2021-01-05
10766881 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Steven W. Andrews, James F. Blake, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt +3 more 2020-09-08
10745419 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more 2020-08-18
10555944 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more 2020-02-11
10519126 Serine/threonine kinase inhibitors James F. Blake, Mark Joseph Chicarelli, Rustam Ferdinand Garrey, John Gaudino, Jonas Grina +6 more 2019-12-31
10441581 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more 2019-10-15
10208024 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Steven W. Andrews, James F. Blake, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt +3 more 2019-02-19